Raphael Rousseau, See Remarks at Gritstone Oncology, Inc. (GRTS), sold 20,000 shares at $0.25 ($253K) on 2021-01-20, disclosed to the SEC on 2021-01-21.
Open-market sale of $253k GRTS by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.25 | 10,000 | $3K | 1.0% |
| 2 | $25.07 | 10,000 | $251K | 99.0% |
| Total | $12.66 avg | 20,000 | $253K | 100% |
| Filing → |
| GRTS | SELL | 2019-08-23 | $108K | — | Filing → |